1. Sequence selectivity of DNA covalent modification
2. NMR Studies of Drug—DNA interactions
3. For leading reviews see: (a) Iyer, V. N.; Szybalski, W.Science1964,145, 55−58. (b) Moore, H. W.; Czerniak, R.Med. Res. Rev.1981,1, 249−280. (c) Remers, W. A.TheChemistry of Antitumor Antibiotics;Wiley: New York, 1979; Vol. 1, pp 221−276. (d) Franck, R. W.; Tomasz, M. InThe Chemistry of Antitumor Agents;Wilman, D. E. V., Ed.; Blackie and Sons, Ltd. Glasgow, Scotland, 1990; pp 379−394. (e) Fisher, J. R.; Aristoff, P. A.Prog. Drug Res.1988,32, 411−498. (f) Tomasz, M. InMolecular Aspects of AnticancerDrug-DNA Interactions;Neidle, S., Waring, M., Eds; Macmillan: Boca Raton, FL, 1994; Vol. 2, pp 312−348.
4. Toward Chemical Ribonucleases. 2. Synthesis and Characterization of Nucleoside-Bipyridine Conjugates. Hydrolytic Cleavage of RNA by Their Copper(II) Complexes